Tech-backed pharmacy benefit manager SmithRx scooped up $20 million in a Series B funding round led by Venrock, with participation from existing investors, including Founders Fund.
The company pitches its Drug Acquisition Platform as a way to provide lower-cost medications, so its employer customers can save on their healthcare spend. According to SmithRx, the platform uses algorithms for each...
